Your browser doesn't support javascript.
loading
Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapy.
Zsiros, Emese; Dangaj, Denarda; June, Carl H; Kandalaft, Lana E; Coukos, George.
Afiliação
  • Zsiros E; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY; Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY.
  • Dangaj D; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.
  • June CH; Department of Pathology & Laboratory Medicine, University of Pennsylvania Philadelphia, PA.
  • Kandalaft LE; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, University Hospital of Lausanne, Switzerland.
  • Coukos G; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, University Hospital of Lausanne, Switzerland.
Oncoimmunology ; 5(5): e1062210, 2016 May.
Article em En | MEDLINE | ID: mdl-27467909
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2016 Tipo de documento: Article